PATENT CLAIM ANALYSIS

Application Number: 15974759
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "229800"]

Abstract:
The present invention relates to the field of therapeutic methods, compositions and uses thereof, that affect, directly or indirectly, the behavior of LRP receptors. These compositions and methods result in the treatment of inflammatory, immunological and metabolic conditions. More particularly, the methods and compositions of the invention are directed to the identification of small molecules, drugs and/or pharmacological agents that affect the Wnt pathway by affecting normal complex formation among various signaling receptors, the LRP5 and LRP6 receptor, and related ligands.

Claim (Index 6):
The method of  claim 5 , wherein the human patient has Diabetes mellitus.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 93.0
- Lexical Diversity: 1.60345
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14680547', '12221863', '12454765', '11598916', '13676630']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7654254893465765
- 35 USC 102 Novelty (BERT): 0.5683261705928266
- Combined Prediction Score: 0.7457155574712016
- Mean Citation Score: 408.2747680000001
- Max Citation Score: 488.94873
- Similarity Product: 343.96390653744214

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test